Noribogaine, but not 18-MC, exhibits similar actions as ibogaine on GDNF expression and ethanol self-administration
Mechanisms Preclinical high
AI-extracted · unverified · confirm at source
Noribogaine increases GDNF expression like ibogaine; 18-MC does not. Intra-VTA noribogaine reduces alcohol self-administration; 18-MC does not. Different mechanisms despite similar anti-addictive profiles. Key for analogue development.
Dosing: 5–50 µM (cell culture); 0.5–4 µg/µl intra-VTA (rats) (not-specified)